Secretory phospholipase A2 (sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2 inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown.
Pharmacology, Toxicology and Pharmaceutical Science
9
4%
Agricultural and Biological Sciences
8
3%
Nursing and Health Professions
7
3%
Other
23
10%
Unknown
86
37%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 97. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2026.
All research outputs
#551,198
of 34,361,833 outputs
Outputs from JAMA: Journal of the American Medical Association
#5,790
of 42,271 outputs
Outputs of similar age
#4,803
of 393,133 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#70
of 332 outputs
Altmetric has tracked 34,361,833 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,271 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 73.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,133 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 332 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.
